AzTrials
AzTrials

Inflammatory Bowel Disease (IBD)NCT06989424

Visualization of the Colon Through Use of the Magnetic Flexible Endoscope (MFE) in Participants With Inflammatory Bowel Disease (IBD)

A study testing Magnetic Flexible Endoscope (MFE) in people with Inflammatory Bowel Disease (IBD) and Colonoscopy, run by Vanderbilt University Medical Center at 1 site in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

In this study, the investigators will test the ability of the Magnetic Flexible Endoscope (MFE) to travel through the colon of people with Inflammatory Bowel Disease (IBD). The MFE is a device made of ultra-flexible tubing that contains a camera, light, and magnet at the tip. Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Inflammatory Bowel Disease (IBD), Colonoscopy
What is being tested?
Magnetic Flexible Endoscope (MFE)
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
6 participants
Where
1 siteUnited States
Study dates
Dec 2026to Jan 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Male or female, 18 to 70 years of age
  • Able to provide written informed consent
  • American Society of Anesthesiologists (ASA) class < 3
  • No significant medical problems
  • Abdominal circumference < 96 cm
  • Stable, non-flaring inflammatory bowel disease (e.g. Ulcerative Colitis and Crohn's Disease)

Who cannot join

  • Patients who do not meet inclusion criteria
  • Patients who are unable or unwilling to provide informed consent
  • Magnetic implants and wearable devices (such as insulin pumps)
  • Females who are pregnant. As part of routine pre-operative care, all females of childbearing potential will undergo either urine or blood pregnancy testing.
  • Cancer positive subjects or any patients currently undergoing any treatment or therapy to treat, cure, or mitigate cancer.
  • Symptoms consistent with coronavirus (COVID-19) --- pyrexia, new persistent cough, or anosmia --- or a positive coronavirus (COVID-19) polymerase chain reaction (PCR) swab result
Show all 19Show fewer
  • Previous incomplete or failed colonoscopy
  • Colonic resection
  • Severe diverticulosis
  • Known or suspected colonic stricture
  • Previous radiation therapy to the abdomen or pelvis
  • Actively flaring inflammatory bowel condition (e.g. active flare of IBD or diverticulitis)
  • Known or suspected bowel obstruction
  • Presence of ascites
  • Participants taking anticoagulant medications or antiplatelet therapy (excluding aspirin) within the last 3 days
  • Known coagulation disorder (INR ≥ 1.5 or platelets < 150 x 109)
  • Known to have phenylketonuria or Glucose-6-Phosphate-Dehydrogenase (G6PD) deficiency
  • Abdominal surgery within the last 6 months
  • Drug or alcohol abuse

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site
  • Vanderbilt University Medical Center

    Nashville, Tennessee, 37232

    Michael G McGill, 615-322-4643, michael.g.mcgill@vumc.org

    Amy Motley, 615-322-6281, amy.motley@vumc.org

Other trials in United States

About this study

In this study, the investigators will test the ability of the Magnetic Flexible Endoscope (MFE) to travel through the colon of people with Inflammatory Bowel Disease (IBD). The MFE is a device made of ultra-flexible tubing that contains a camera, light, and magnet at the tip. The tip of the tube is about the size of a penny. The magnet inside the tip allows the MFE to be moved through the colon by a second magnet attached to a robotic arm that is outside the body. The purpose of this study is to see how the MFE travels through the colon of IBD patients and if it is tolerable.

Read the detailed description

Colonoscopy is the gold standard for making the diagnosis, following clinical response, establishing prognosis, and creation of management plans for patients with Inflammatory Bowel Disease (IBD). While colonoscopy is a relatively safe procedure, there are several limitations due to the unintuitive drive mechanism and mechanical design of current conventional colonoscopes. Additionally, for patients with IBD, the procedure is associated with a higher lifetime risk of adverse event due to increased frequency of examination-more than a 6-fold increased risk when compared to their non-IBD counterparts.

For these reasons, our team has developed a novel, highly compliant, Magnetic Flexible Endoscope (MFE) with the functionality of a conventional colonoscope (i.e. camera, therapeutic channel, irrigation, insufflation, illumination, lens cleaning). The MFE is driven by magnetic coupling of the endoscope head that contains an internal permanent magnet and a robotic arm that holds an external permanent magnet. This enables a "front-pull" actuation mechanism to eliminate the need for pushing a semi-rigid insertion tube for advancement. The forward drive mechanism thus prevents buckling of the insertion tube and avoids looping/colon wall stress. This reduces the risk of perforation and pain during the procedure to allow for less (if any) procedural sedation.

The Magnetic Flexible Endoscope (MFE) is a single-use endoscope intended to integrate with other commercially available devices for the visualization of a human colon in order to eliminate the need for passage of the much stiffer, non-intuitive, risk prone standard colonoscope. This study builds on the successful completion of the first-in-human feasibility study that demonstrated safety and tolerability in healthy patients who were already scheduled for their routine standard-of-care screening colonoscopy. In this secondary study, the MFE device will be inserted into the rectum via the anus and navigated through the colon to the cecum, using magnetic manipulation, in patients with stable, non-active, Inflammatory Bowel Disease (IBD) who are due for their IBD/colorectal cancer surveillance/screening colonoscopy exams.

The investigators plan to assess safety and tolerability of MFE navigation in the colon from the rectum to the cecum in patients with stable non-active IBD who are due for their IBD/Colorectal Cancer surveillance/screening colonoscopy exams. This will be a parallel study design in which three of six patients will have standard of care colonoscopy completed with monitored anesthesia care (MAC) first followed by MFE and three of six patients will undergo unsedated MFE first followed by standard of care colonoscopy completed with MAC.

Being tested
Magnetic Flexible Endoscope (MFE)
Keywords
Colonoscopy, Colon, Robotic, Magnetic, Endoscopy, Inflammatory Bowel Disease (IBD)
Medical subject headings
Inflammatory Bowel Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Magnetic Flexible Endoscope (MFE)Device

    The Magnetic Flexible Endoscope (MFE) is a single-use endoscope intended to integrate with other commercially available devices for visualization of the human colon in order to eliminate the need for passage of the much stiffer, non-intuitive, risk prone standard colonoscope. The MFE will be introduced into the colon and traverse from the rectum to the cecum.

Study groups in NCT06989424
Study groupRoleWhat they receive
Standard of Care (SOC) colonoscopy followed by Magnetic Flexible Endoscope (MFE)ExperimentalPatients in this group will have their SOC colonoscopy for IBD/colorectal cancer screening completed with a legacy colonoscope followed by colonoscopy with the MFE.
Receives: Device: Magnetic Flexible Endoscope (MFE)
Colonoscopy with Magnetic Flexible Endoscope (MFE) followed by Standard of Care (SOC) colonoscopyExperimentalPatients in this group will have colonoscopy with the MFE followed by the legacy colonoscope for standard of care IBD/colorectal cancer screening.
Receives: Device: Magnetic Flexible Endoscope (MFE)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility to intubate the cecum (yes/no)

    Ability to feasibly enter the cecum of the colon. Will be confirmed per standard endoscopic practice of visualizing and photo documenting at least 2 of the 3 common cecum landmarks (ileocecal valve, triradiate fold, appendiceal orifice).

    Measured: Day 1

Secondary outcomes (3)
  1. Mucosal visibility

    Operator assessed score, the Colon Visualization Index, will be used. Scale ranges from 0 (poor) to 4 (excellent)

    Measured: Day 1

  2. Patient tolerance

    Pain perception will be assessed with a validated pain score (Wong-Baker FACES Pain Rating Scale) with 0 be no hurt to 10 hurts worst during a post-study structured interview.

    Measured: Day 1

  3. Endoscopist experience

    Usability of the platform in terms of task load for the endoscopist will be assessed using the standardized validated National Aeronautics and Space Administration (NASA) Task Load Index (TLX) based on a multidimensional construct of six sub-scales: mental demand, physical demand, temporal demand, performance, effort, and frustration level. The sub-scales range from 0 (very low) to 100 (very high): the exception is the sub-scale of performance, where 0 is perfect and 100 is failure.

    Measured: Day 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 May 2025
  2. Study startDec 2026 (estimated)
  3. Primary completionJul 2028 (estimated)
  4. Study completionJan 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Device feasibility
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
6 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06989424
Sponsor's protocol ID
MFEIBD_241894
Other IDs
5R01EB018992-08
Status last verified
Aug 2026
First submitted
9 May 2025
Last updated
20 Aug 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Magnetic Flexible Endoscope (MFE) in people with Inflammatory Bowel Disease (IBD) and Colonoscopy, run by Vanderbilt University Medical Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 19 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 20 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Michael G McGill (615-322-4643, michael.g.mcgill@vumc.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility to intubate the cecum (yes/no) (time frame: Day 1). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Aug 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in